Showing results (1-10 of 175) with videos related to
Sort By:
Pageof 18
Frontiers in Immunology|March 16, 2019
Targeting Lipooligosaccharide (LOS) for a Gonococcal VaccineSunita Gulati, Jutamas Shaughnessy, Sanjay Ram, et al.Immunobiology|June 15, 2016
Utilizing complement evasion strategies to design complement-based antibacterial immunotherapeutics: Lessons from the pathogenic NeisseriaeSanjay Ram, Jutamas Shaughnessy, Rosane B DeOliveira, et al.Methods in Molecular Biology (Clifton, N.J.)|May 24, 2019
Biology of the Gonococcus: Disease and PathogenesisJutamas Shaughnessy, Sanjay Ram, Peter A RicePathogens and Disease|May 2, 2017
Gonococcal lipooligosaccharide sialylation: virulence factor and target for novel immunotherapeuticsSanjay Ram, Jutamas Shaughnessy, Rosane B de Oliveira, et al.Methods in Molecular Biology (Clifton, N.J.)|May 24, 2019
Complement-Dependent Serum Bactericidal Assays for Neisseria gonorrhoeaeSunita Gulati, Peter A Rice, Sanjay RamMbio|October 31, 2023
Preclinical efficacy of a cell division protein candidate gonococcal vaccine identified by artificial intelligenceSunita Gulati, Andreas Holm Mattsson, Sophie Schussek, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 28, 2012
Properdin is critical for antibody-dependent bactericidal activity against Neisseria gonorrhoeae that recruit C4b-binding proteinSunita Gulati, Sarika Agarwal, Shreekant Vasudhev, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 9, 2002
Regulation of the mannan-binding lectin pathway of complement on Neisseria gonorrhoeae by C1-inhibitor and alpha 2-macroglobulinSunita Gulati, Kedarnath Sastry, Jens C Jensenius, et al.Mbio|November 7, 2019
Preclinical Efficacy of a Lipooligosaccharide Peptide Mimic Candidate Gonococcal VaccineSunita Gulati, Michael W Pennington, Andrzej Czerwinski, et al.Infection and Immunity|November 23, 2011
Enhanced bacteremia in human factor H transgenic rats infected by Neisseria meningitidisDavid M Vu, Jutamas Shaughnessy, Lisa A Lewis, et al.Pageof 18